Trials / Completed
CompletedNCT05649813
A Study in Male and Female Adult Participants With Chronic Rhinosinusitis With Nasal Polyps In the Greater Gulf Region
Prospective Registry on Chronic RhinoSinusitis With Nasal Polyps In the Greater Gulf Region
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 148 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Primary Objective: \- To describe the clinical characteristics of participants with chronic rhinosinusitis with nasal polyps (CRSwNP) in terms of disease severity, Type 2 inflammation-related comorbidities (such as asthma and allergic rhinitis), other associated comorbidities, and treatments used in a real-world setting Secondary Objectives: * Describe the progression in treatment outcomes at different visits (baseline, 3 months, 6 months, and 12 months). * To assess the healthcare resource utilization of participants with CRSwNP in countries of the Gulf region (number of visits, emergency room (ER), surgery, etc).
Conditions
Timeline
- Start date
- 2022-11-20
- Primary completion
- 2024-06-14
- Completion
- 2024-06-14
- First posted
- 2022-12-14
- Last updated
- 2024-07-11
Locations
1 site across 1 country: Kuwait
Source: ClinicalTrials.gov record NCT05649813. Inclusion in this directory is not an endorsement.